Republic of Korea vs Zimbabwe: Drug use disorder deaths by sex
Republic of Korea
31.19 deaths
in 2021
Zimbabwe
28.77 deaths
in 2021
Republic of Korea rank
53rd
Zimbabwe rank
54th
Drug use disorder deaths by sex over time
- Republic of Korea
- Zimbabwe
How they compare
Republic of Korea currently reports 31.19 deaths against 28.77 deaths in Zimbabwe, a difference of 2.42 deaths.
That makes Republic of Korea's figure about 1.1 times Zimbabwe's.
The two have swapped places 4 times across 22 shared years of data; in 2000 it was Republic of Korea ahead.
Republic of Korea ranks 53rd and Zimbabwe ranks 54th of 194 countries.
Across the 3 decades both report, Republic of Korea averaged higher in 2 and Zimbabwe in 1.
Head to head by decade
| Decade | Republic of Korea | Zimbabwe | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 18.79 deaths | 14.4 deaths | 4.39 deaths | Republic of Korea |
| 2010s | 17.82 deaths | 20.63 deaths | 2.81 deaths | Zimbabwe |
| 2020s | 27.49 deaths | 26.65 deaths | 0.84 deaths | Republic of Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher drug use disorder deaths by sex, Republic of Korea or Zimbabwe?
- Republic of Korea, at 31.19 deaths against 28.77 deaths in Zimbabwe as of 2021.
- What is the difference in drug use disorder deaths by sex between Republic of Korea and Zimbabwe?
- 2.42 deaths, with Republic of Korea ahead.
- How many years of comparable data are there for Republic of Korea and Zimbabwe?
- 22 years are reported by both, from 2000 to 2021.
- How do Republic of Korea and Zimbabwe rank globally for drug use disorder deaths by sex?
- Republic of Korea ranks 53rd and Zimbabwe ranks 54th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) β with major processing by Our World in Data, published as Drug use disorder deaths by sex. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from drug use disorders in females.